文献速递药物不良反应与药物警戒

COVID-19疫苗用药错误报告中MedDRA编码质量评估

Quality of MedDRA® Coding in a Sample of COVID-19 Vaccine Medication Error Data.
PubMed 文献 · Drug Saf · 2023-04-23

该研究由两名MedDRA专家采用四眼原则,对 Uppsala Monitoring Centre 数据库中截至2021年8月25日报告的1500条COVID-19疫苗用药错误术语的MedDRA编码进行质量评估。结果显示三分之一记录因原文不完整或不清无法评估,三分之一编码正确,另三分之一编码不充分,最常见错误为尽管原文有更详细信息却仍分配模糊的优选术语。结论提示需加强用药错误文档理解、病例叙述信息准确提取及MedDRA内容和编码指南知识。

要点

  • 约三分之一用药错误报告因原文不完整或不清无法评估编码质量。
  • 可评估记录中约三分之一MedDRA编码不正确或不够充分。
  • 最常见编码错误为原文有更详细信息时仍分配模糊的优选术语。

核心结论

  • 用药错误文档理解、病例叙述信息准确提取及MedDRA内容和编码指南知识需要加强。
  • 编码错误模式与EudraVigilance数据库观察相似,常见模糊概念被频繁分配。

研究设计与样本

  • 由两名MedDRA专家应用四眼原则评估编码术语样本。
  • 样本包括来自Uppsala Monitoring Centre数据库截至2021年8月25日报告的1500条COVID-19疫苗用药错误术语及其分配的MedDRA术语。

主要发现

  • 三分之一记录因原文不完整或不清无法评估。
  • 三分之一记录MedDRA术语分配正确。
  • 另三分之一样本编码不充分。
  • 最常见编码错误为尽管原文有更详细信息可用于更精确编码,却分配了模糊的MedDRA优选术语。

临床怎么用

  • 编码用药错误报告时应仔细提取病例叙述中的详细信息,避免分配模糊优选术语。
  • 需熟悉MedDRA内容和编码指南,并参考ICH认可的MedDRA用户指南及培训资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In recent years, there has been increasing interest from regulatory agencies and scientific organisations into the recording, coding and reporting of medication errors. Accuracy and consistency in the handling of medication error reports ensure the safety and effectiveness of medicines and provide reliable information to both healthcare professionals and patients. OBJECTIVE: The authors have examined a sample of Medical Dictionary for Regulatory Activities (MedDRA®) coded reports that describe medication errors to assess the accuracy and consistency of MedDRA® coding, and to identify the main types of coding errors for the newly introduced COVID-19 vaccines. METHODS: The sample of coded terms was assessed by two MedDRA® experts applying the Four Eyes Principle. It included 1500 reported terms drawn from the Uppsala Monitoring Centre database reported up to 25 August, 2021, describing medication errors for COVID-19 vaccines with their assigned MedDRA® terms. RESULTS: One third of the records could not be assessed because of incomplete or unclear verbatims. In one third, MedDRA® term assignments were correct, but another third of the sample was not adequately coded. The most frequent coding errors corresponded to vague MedDRA® Preferred Term assignments despite more detailed information being available in the verbatim for a more precise coding. This observation is similar to findings in the EudraVigilance database, where some of the most frequently assigned MedDRA® terms for medication errors also represent vague concepts. CONCLUSIONS: The findings indicate that understanding of medication error documentation and of the importance of accurate extraction of information from case narratives, as well as knowledge of MedDRA® content and coding guidelines need to be reinforced. The authors provide useful references to training opportunities and to the applicable International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use-Endorsed Guides for MedDRA® users.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Kralova K, Wilson CA, Richebourg N, et al. Quality of MedDRA® Coding in a Sample of COVID-19 Vaccine Medication Error Data. Drug Saf. 2023. PMID: 37087705. doi:10.1007/s40264-023-01294-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。